Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
603 | 3259 | 30.8 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
216 | 3 | NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG | 51214 |
337 | 2 | THORAC SURG//LUNG CANCER//RESPIRATORY SYSTEM | 17838 |
603 | 1 | NON SMALL CELL LUNG CANCER//STAGE III//LOCALLY ADVANCED NON SMALL CELL LUNG CANCER | 3259 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NON SMALL CELL LUNG CANCER | authKW | 789754 | 28% | 9% | 903 |
2 | STAGE III | authKW | 359846 | 3% | 47% | 82 |
3 | LOCALLY ADVANCED NON SMALL CELL LUNG CANCER | authKW | 300428 | 1% | 76% | 42 |
4 | N2 DISEASE | authKW | 188299 | 1% | 72% | 28 |
5 | LOCALLY ADVANCED NSCLC | authKW | 186240 | 1% | 76% | 26 |
6 | LUNG CANCER | journal | 178063 | 9% | 7% | 290 |
7 | STAGE IIIA | authKW | 158296 | 1% | 65% | 26 |
8 | INDUCTION CHEMOTHERAPY | authKW | 108131 | 2% | 15% | 79 |
9 | JOURNAL OF THORACIC ONCOLOGY | journal | 86186 | 5% | 6% | 157 |
10 | STAGE III NSCLC | authKW | 85159 | 0% | 91% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 60353 | 69% | 0% | 2259 |
2 | Respiratory System | 50268 | 32% | 1% | 1056 |
3 | Radiology, Nuclear Medicine & Medical Imaging | 6173 | 18% | 0% | 577 |
4 | Surgery | 2433 | 16% | 0% | 534 |
5 | Cardiac & Cardiovascular System | 2272 | 11% | 0% | 374 |
6 | Critical Care Medicine | 710 | 3% | 0% | 105 |
7 | Medicine, General & Internal | 102 | 4% | 0% | 143 |
8 | MEDICINE, MISCELLANEOUS | 4 | 0% | 0% | 1 |
9 | Asian Studies | 1 | 0% | 0% | 3 |
10 | Anatomy & Morphology | 1 | 0% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MULTIDISCIPLINARY THORAC ONCOL PROGRAM | 82614 | 1% | 29% | 30 |
2 | THORAC SURG | 81207 | 13% | 2% | 417 |
3 | RADIAT ONCOL | 80526 | 23% | 1% | 750 |
4 | THORAC ONCOL | 38794 | 3% | 4% | 93 |
5 | RADIOTHER IE ONCOL | 21577 | 0% | 14% | 16 |
6 | MEDASSISTANCE PUBL HOP MARSEILLE | 21076 | 0% | 75% | 3 |
7 | CANC PREVENT TIANJIN | 18735 | 0% | 100% | 2 |
8 | HEMATOL MED ONCOL P MED | 18735 | 0% | 100% | 2 |
9 | OPERAT UNIT PULM ONCOL 5 | 18735 | 0% | 100% | 2 |
10 | P TUMOR UNIT | 18735 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LUNG CANCER | 178063 | 9% | 7% | 290 |
2 | JOURNAL OF THORACIC ONCOLOGY | 86186 | 5% | 6% | 157 |
3 | CLINICAL LUNG CANCER | 71152 | 2% | 10% | 76 |
4 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 52017 | 10% | 2% | 310 |
5 | SEMINARS IN ONCOLOGY | 21646 | 3% | 2% | 110 |
6 | SEMINARS IN RADIATION ONCOLOGY | 14404 | 1% | 4% | 35 |
7 | RADIOTHERAPY AND ONCOLOGY | 12079 | 3% | 1% | 88 |
8 | EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 8803 | 3% | 1% | 88 |
9 | ANNALS OF THORACIC SURGERY | 8397 | 4% | 1% | 138 |
10 | JOURNAL OF CLINICAL ONCOLOGY | 8032 | 4% | 1% | 119 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NON SMALL CELL LUNG CANCER | 789754 | 28% | 9% | 903 | Search NON+SMALL+CELL+LUNG+CANCER | Search NON+SMALL+CELL+LUNG+CANCER |
2 | STAGE III | 359846 | 3% | 47% | 82 | Search STAGE+III | Search STAGE+III |
3 | LOCALLY ADVANCED NON SMALL CELL LUNG CANCER | 300428 | 1% | 76% | 42 | Search LOCALLY+ADVANCED+NON+SMALL+CELL+LUNG+CANCER | Search LOCALLY+ADVANCED+NON+SMALL+CELL+LUNG+CANCER |
4 | N2 DISEASE | 188299 | 1% | 72% | 28 | Search N2+DISEASE | Search N2+DISEASE |
5 | LOCALLY ADVANCED NSCLC | 186240 | 1% | 76% | 26 | Search LOCALLY+ADVANCED+NSCLC | Search LOCALLY+ADVANCED+NSCLC |
6 | STAGE IIIA | 158296 | 1% | 65% | 26 | Search STAGE+IIIA | Search STAGE+IIIA |
7 | INDUCTION CHEMOTHERAPY | 108131 | 2% | 15% | 79 | Search INDUCTION+CHEMOTHERAPY | Search INDUCTION+CHEMOTHERAPY |
8 | LUNG CANCER | 94349 | 13% | 2% | 438 | Search LUNG+CANCER | Search LUNG+CANCER |
9 | STAGE III NSCLC | 85159 | 0% | 91% | 10 | Search STAGE+III+NSCLC | Search STAGE+III+NSCLC |
10 | CONCURRENT CHEMORADIOTHERAPY | 82194 | 2% | 16% | 56 | Search CONCURRENT+CHEMORADIOTHERAPY | Search CONCURRENT+CHEMORADIOTHERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RAMNATH, N , DILLING, TJ , HARRIS, LJ , KIM, AW , MICHAUD, GC , BALEKIAN, AA , DIEKEMPER, R , DETTERBECK, FC , ARENBERG, DA , (2013) TREATMENT OF STAGE III NON-SMALL CELL LUNG CANCER DIAGNOSIS AND MANAGEMENT OF LUNG CANCER, 3RD ED: AMERICAN COLLEGE OF CHEST PHYSICIANS EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES.CHEST. VOL. 143. ISSUE 5. P. E314-E340 | 83 | 75% | 62 |
2 | WILLERS, H , STINCHCOMBE, TE , BARRIGER, RB , CHETTY, IJ , GINSBURG, ME , KESTIN, LL , KUMAR, S , LOO, BW , MOVSAS, B , RIMNER, A , ET AL (2015) ACR APPROPRIATENESS CRITERIA (R) INDUCTION AND ADJUVANT THERAPY FOR N2 NON-SMALL-CELL LUNG CANCER.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. VOL. 38. ISSUE 2. P. 197 -205 | 72 | 90% | 3 |
3 | ROBINSON, LA , RUCKDESCHEL, JC , WAGNER, H , STEVENS, CW , (2007) TREATMENT OF NON-SMALL CELL LUNG CANCER-STAGE IIIA - ACCP EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES (2ND EDITION).CHEST. VOL. 132. ISSUE 3. P. 243S-265S | 69 | 86% | 128 |
4 | EBERHARDT, WEE , DE RUYSSCHER, D , WEDER, W , LE PECHOUX, C , DE LEYN, P , HOFFMANN, H , WESTEEL, V , STAHEL, R , FELIP, E , PETERS, S , (2015) 2ND ESMO CONSENSUS CONFERENCE IN LUNG CANCER: LOCALLY ADVANCED STAGE III NON-SMALL-CELL LUNG CANCER.ANNALS OF ONCOLOGY. VOL. 26. ISSUE 8. P. 1573 -1588 | 64 | 62% | 36 |
5 | DUPIC, G , BELLIERE-CALANDRY, A , (2016) POSTOPERATIVE RADIOTHERAPY FOR NON-SMALL CELL LUNG CANCER: EFFICACY, TARGET VOLUME, DOSE.CANCER RADIOTHERAPIE. VOL. 20. ISSUE 2. P. 151 -159 | 58 | 87% | 0 |
6 | AWAN, M , SHARMA, N , TOWE, CW , EFIRD, JT , MACHTAY, M , BISWAS, T , (2016) OPTIMUM TREATMENT FOR MEDIASTINAL LYMPH NODE POSITIVE (N2) RESECTABLE NON-SMALL CELL LUNG CANCER: WHAT IS THE ROLE FOR SURGERY?.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 16. ISSUE 11. P. 1131 -1144 | 60 | 83% | 0 |
7 | LE PECHOUX, C , (2011) ROLE OF POSTOPERATIVE RADIOTHERAPY IN RESECTED NON-SMALL CELL LUNG CANCER: A REASSESSMENT BASED ON NEW DATA.ONCOLOGIST. VOL. 16. ISSUE 5. P. 672 -681 | 58 | 83% | 42 |
8 | JEREMIC, B , (2015) STANDARD TREATMENT OPTION IN STAGE III NON-SMALL-CELL LUNG CANCER: CASE AGAINST TRIMODAL THERAPY AND CONSOLIDATION DRUG THERAPY.CLINICAL LUNG CANCER. VOL. 16. ISSUE 2. P. 80 -85 | 49 | 98% | 1 |
9 | JEREMIC, B , CASAS, F , DUBINSKY, P , GOMEZ-CAAMANO, A , CIHORIC, N , VIDETIC, G , (2016) SURGERY FOR STAGE IIIA NON-SMALL-CELL LUNG CANCER: LACK OF PREDICTIVE AND PROGNOSTIC FACTORS IDENTIFYING ANY SUBGROUP OF PATIENTS BENEFITING FROM IT.CLINICAL LUNG CANCER. VOL. 17. ISSUE 2. P. 107 -112 | 52 | 91% | 0 |
10 | JEREMIC, B , MILICIC, B , MILISAVLJEVIC, S , (2013) RADIOTHERAPY ALONE VS. RADIOCHEMOTHERAPY IN PATIENTS WITH FAVORABLE PROGNOSIS OF CLINICAL STAGE IIIA NON-SMALL-CELL LUNG CANCER.CLINICAL LUNG CANCER. VOL. 14. ISSUE 2. P. 172 -180 | 49 | 100% | 2 |
Classes with closest relation at Level 1 |